CClinicalTrials.gg
CompletedNCT01977664Updated Nov 7, 2013

In Vitro Maturation Induction of Oocytes From a Woman With Syndrome of Repeated Oocyte Maturation Failure in Vitro

An observational study in Oocyte Maturation Failure, sponsored by The Second Affiliated Hospital of Kunming Medical University. Completed at 1 site in China. Open to female participants aged 32 Years to 32 Years. Per ClinicalTrials.gov, last updated 2013-11-07.

Sponsored by The Second Affiliated Hospital of Kunming Medical University · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
1
Ages
32 Years to 32 Years
Sex
Female
01

Study summary

Donated oocytes is from a patient with repeated oocyte maturation failure in IVF cycles. Cytoplasm of matured metaphase II oocyte and active MPF were injected into the donated oocytes.

Read the detailed description

The study reported a woman with syndrome of repeated oocyte maturation failure where there is repeated production of immature oocytes.She underwent two IVF cycles in other hospital. All oocytes obtained were immature and the treatment were stopped.She underwent her third try in our hospital. The couple gave their informed consent: ICSI will be performed if maturation occurred, otherwise, the treatment would be stopped and the oocytes would be donated for study if the oocytes were not matured after 24 hours of culture. After ovarian hyperstimulation,14 oocytes were obtained. None of them was matured. The cycle was canceled and the oocytes were donated for study.To induce the immature oocytes in vitro, oocytes were 1)cultured in follicular fluid containing matured metaphase II oocyte; 2) performed intracytoplasmic sperm injection (ICSI) to induce intracellular Ca2+]i oscillations; 3)injected with active maturation promoting factor (MPF), 4)injected with cytoplasm of matured metaphase II oocyte.

02

Conditions studied

  • Oocyte Maturation Failure

Keywords

  • oocyte maturation failure
  • Maturation induction in vitro
03

In context

Lead sponsor

The Second Affiliated Hospital of Kunming Medical University is the lead sponsor of 17 studies on the registry; 11 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
32 Years to 32 Years
Sexes eligible
Female
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

a patient with repeated oocyte maturation failure in IVF cycles

Inclusion criteria

Clinical diagnosis of syndrome of repeated oocyte maturation

Exclusion criteria

Exclusion Criteria:

patients with matured oocytes in IVF cycles

05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
1 participant (actual)
Patient registry
No

Groups and cohorts

  • oocyte maturation failure

    no intervention

    Other: no intervention

Interventions

  • Otherno intervention
06

What researchers measure

Primary outcomes

  1. Oocyte nucleus maturation

    Time frame: April,2012

07

Study locations

1 site
  • The Second Affiliated Hospital of Kunming Medical University
    Kunming, Yunnan 650101, China
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 7, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01977664
Lead sponsor
The Second Affiliated Hospital of Kunming Medical University
Responsible party
Yang Jie (Principal Investigator, The Second Affiliated Hospital of Kunming Medical University) — Principal investigator
First posted
Nov 7, 2013
Start date
Mar 2012
Primary completion
Apr 2012
Completion
Apr 2012
Last update
Nov 7, 2013

Study contacts

Jie Yang, M.Sc
principal investigator · The Second Affiliated Hospital of Kunming Medical University

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion